Harutoshi Fujimura

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 900 citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Neurological Disorder +6

Muscleblind-like 2-Mediated Alternative Splicing in the Developing Brain and Dysregulation in Myotonic Dystrophy

Konstantinos Charizanis, Kuang-Yung Lee, Ranjan Batra et al. · Neuron · 2012 · 341 citations · Full text

Developmental Biology, Molecular Neuroscience, Skeletal Muscle +9

Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2

Atsushi Kumanogoh, Satoko Marukawa, Kazuhiro Suzuki et al. · Nature · 2002 · 325 citations

Signal Transduction, Immunology, T-cell Activation +8

Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy

Frédérique Rau, Fernande Freyermuth, Charlotte Fugier et al. · Nature Structural & Molecular Biology · 2011 · 274 citations

Heart Defects, Cardiomyopathy, Heart Failure +12

Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1

Takashi Kimura, Masayuki Nakamori, John D. Lueck et al. · Human Molecular Genetics · 2005 · 271 citations · Full text